Belatacept Conversion in Kidney Transplant: With or without Calcineurin Inhibitor Taper

被引:0
|
作者
Elmasri, A. [1 ]
Valdepenas, B. [1 ]
Benken, S. [1 ]
Hajjiri, Z. [2 ]
Benken, J. [1 ]
机构
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois Hosp & Hlth Sci Syst, Chicago, IL USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
B202
引用
收藏
页码:S845 / S846
页数:2
相关论文
共 50 条
  • [31] Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients
    Crew, R.
    Patel, S.
    Pai, A.
    Batal, I.
    Fernandez, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 397 - 397
  • [32] 7-YEARS RETROSPECTIVE COHORT OF CALCINEURIN INHIBITOR (CNI) TO BELATACEPT CONVERSION
    Morel, Antoine
    Dudreuilh, Caroline
    Moktefi, Anissa
    Kheav, David
    Mokrani, David
    El Sakhawi, Karim
    Champy, Cecile
    Remy, Philippe
    Grimbert, Philippe
    Matignon, Marie
    TRANSPLANTATION, 2020, 104 (09) : S362 - S362
  • [33] Belatacept conversion in adolescent and young adult kidney transplant recipients
    Gupta, Charu
    Petyak, Christy
    Sgambat, Kristen
    Moudgil, Asha
    CLINICAL TRANSPLANTATION, 2023, 37 (03)
  • [34] Kidney Transplant Function After Late Conversion to Belatacept (Nulojix®)
    Brakemeier, S.
    Duerr, M.
    Wiesener, M.
    Tobias, B.
    Budde, K.
    Klemens, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [35] Arterial Stiffness in Kidney Transplantation: Belatacept Versus Calcineurin Inhibitor Based Regimen
    Melilli, E.
    Bestard, O.
    Cruzado, J.
    Gelpi, R.
    Grinyo, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 285 - 286
  • [36] Prospective, Randomized Study of Conversion from Calcineurin Inhibitor (CNI)- to Belatacept (BELA)-Based Maintenance Immunosuppression in Renal Transplant Recipients
    Budde, K.
    Prashar, R.
    Haller, H.
    Rial, M.
    Kamar, N.
    Agarwal, A.
    de Fijter, J.
    Rostaing, L.
    Berger, S.
    Djamali, A.
    Leca, N.
    Allamassey, L.
    Gao, S.
    Polinsky, M.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 437 - 438
  • [37] Late Conversion From Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
    Terrec, Florian
    Jouve, Thomas
    Naciri-Bennani, Hamza
    Benhamou, Pierre-Yves
    Malvezzi, Paolo
    Janbon, Benedicte
    Giovannini, Diane
    Rostaing, Lionel
    Noble, Johan
    TRANSPLANTATION DIRECT, 2020, 6 (01): : E517
  • [38] Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
    Noble, J.
    Terrec, F.
    Jouve, T.
    Bennani, H. Neciri
    Benhamou, P.
    Malvezzi, P.
    Janbon, B.
    Giovannini, D.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 927 - 927
  • [39] Improved Renal Outcomes in Kidney Transplant Recipients with Early Denovo DSAs on Belatacept versus Calcineurin Inhibitor-Based Immunosuppression
    Gattis, S.
    Agrawal, M.
    Pang, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S698 - S698
  • [40] Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
    Karpe, Krishna M.
    Talaulikar, Girish S.
    Walters, Giles D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07):